| Authors: |
Hill NR; Bristol-Myers Squibb Co R&D Lawrenceville, Lawrenceville, New Jersey, USA., Dotson T; Pulmonary/Critical Care, Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, USA., Maus SE; Pulmonary/Critical Care, Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, USA., Bellinger C; Pulmonary/Critical Care, Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, USA., Mehta V; Comprehensive Cancer Centers of Nevada, Henderson, Nevada, USA., Rings A; Optellum Ltd, Oxford, UK annika.rings@optellum.com., Pickup LC; Optellum Ltd, Oxford, UK., Waterfield Price N; Optellum Ltd, Oxford, UK., Potěšil V; Optellum Ltd, Oxford, UK., Carbone DP; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Pannu J; The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. |
